Edema Extension Distance: Outcome Measure for Phase II Clinical Trials Targeting Edema After Intracerebral Hemorrhage

Affiliations

• ¹ From the Centre for Vascular and Stroke Research, Manchester Academic Health Sciences Centre, Salford Royal NHS Foundation Trust (A.R.P.-J., A.V.) and Centre for Biostatistics (A.V.), University of Manchester, Manchester, United Kingdom; Greater Manchester Comprehensive Stroke Centre, Salford Royal NHS Foundation Trust, Salford, United Kingdom (A.R.P.-J.); Neurological and Mental Health Division, The George Institute for Global Health, University of Sydney and Royal Prince Alfred Hospital, Sydney, Australia (X.W., S.S., C.S.A.); and Division of Brain Injury Outcomes, Department of Neurology, Johns Hopkins Medical Institutions, Baltimore, MD (W.A.M., D.F.H.). adrian.parry-jones@manchester.ac.uk.
• ² From the Centre for Vascular and Stroke Research, Manchester Academic Health Sciences Centre, Salford Royal NHS Foundation Trust (A.R.P.-J., A.V.) and Centre for Biostatistics (A.V.), University of Manchester, Manchester, United Kingdom; Greater Manchester Comprehensive Stroke Centre, Salford Royal NHS Foundation Trust, Salford, United Kingdom (A.R.P.-J.); Neurological and Mental Health Division, The George Institute for Global Health, University of Sydney and Royal Prince Alfred Hospital, Sydney, Australia (X.W., S.S., C.S.A.); and Division of Brain Injury Outcomes, Department of Neurology, Johns Hopkins Medical Institutions, Baltimore, MD (W.A.M., D.F.H.).